Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of weekly versus three-times-weekly paclitaxel concurrent with radiotherapy in locally advanced non-small cell lung cancer
ChiCTR-TRC-10000786Phase 3Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: Progression-free survival, Median survival and 2 more. Started Jun 2007; status: completed.
02
Drugs
paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000786.